The Burden of Healthcare Associated Infections - April 11, 2016

Throughout the world, hundreds of millions of patients are affected every year with healthcare associated infections (HCAIs). According to WHO, "the burden of HCAI is several fold higher in low- and middle-income countries than in high-income ones". However, these numbers in both areas are still great and range from 7 out of 100 of patients admitted to hospitals in developed world countries to 10 out of 100 of patients admitted to hospitals in developing world countries at any given time. 

HCAIs are infections contracted during the care process at any healthcare facility. They can affect patients in any type of care setting and can also appear after discharge from the facilities. Patients affected with the negative outcomes of contracting an HCAI can result in "prolonged hospital stays, long-term disability, increased resistance of microorganisms to antimicrobials, massive additional costs for health systems, high costs for patients and their family, and unnecessary deaths." 

Although HCAIs occur at a high frequency, many countries still struggle with diagnosis of these infections and how to deal with them. WHO highlights and reports data on the HCAI endemic burden throughout the world but even then the true burden of HCAIs is greatly underestimated. By implementing increased education about HCAIs in the healthcare industry, improving staff and accountability, implementing standard precautions, and having core components of infection control there can be many potential solutions for improvement in reducing healthcare associated infections. 

UVC Cleaning Systems is committed to reducing infections and illness caused by bacteria and viruses affecting millions of people on a global scale. Our products are another component that can be added to infection control in reducing the numbers of HCAIs before patients are even infected. We target major HCAIs such as C. difficile, MRSA, and S. aureus during environmental cleaning of facilities. We hope that actively working towards an effective way to improve global healthcare can help prevent lives lost to HCAIs. 

Update on 222nm Exposure and ACGIH Eye Exposure Safety

Finally! We get some real world explanation of TLVs (Threshold Limit Values) and effects on eye radiation using 222 nm technology. A recently published article by the Council for Optical Radiation Measurements titled "Expected ACGIH Eye Exposure When Using 222 nm Ceiling Mounted Sources" gives some vital updates all 222nm users and future users should be aware of.

Far UV-C is the answer to our Pandemic fears

Could Far UV-C (222) help the fight against not only Covid-19 and its many variants, but Monkeypox as well? The answer is yes, yes it can. This article from Biospace.com explains Far UV-C and how it inactivates pathogens. Being that Monkeypox...

222 is the Future of Disinfection at UVC

    For decades, UV-C wavelengths of light have been used to disinfect everything from water to walls. In more recent years 254 nm wavelengths of UV-C light have been the standard in the fight against pathogens. However, there is a...
Page: 1234567 - All